Drug developer Millennium and Takeda Pharmaceutical said today the European Commission has granted conditional marketing authorization for a drug that treats certain forms of lymphoma.
Takeda, which bought Millennium for $8.8 billion in 2008, said it plans to launch Adcetris across Europe in the coming weeks.
The U.S. Food and Drug Administration approved Adcetris to be marketed in the U.S. in August 2011.
Anda sedang membaca artikel tentang
Millennium lymphoma drug wins European approval
Dengan url
http://emberemas.blogspot.com/2012/11/millennium-lymphoma-drug-wins-european.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Millennium lymphoma drug wins European approval
namun jangan lupa untuk meletakkan link
Millennium lymphoma drug wins European approval
sebagai sumbernya
0 komentar:
Posting Komentar